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Additive manufacturing (AM) is a rapidly emerging technology that has the potential to produce 
personalized scaffolds for tissue engineering applications with unprecedented control of structural 
and functional design. Particularly for bone defect regeneration, the complex coupling of biological 
mechanisms to the scaffolds’ properties has led to a predominantly trial-and-error approach. To 
mitigate this, shape or topology optimization can be a useful tool to design a scaffold architecture 
that matches the desired design targets, albeit at high computational cost. Here, we consider an 
efficient macroscopic optimization routine based on a simple one-dimensional time-dependent 
model for bone regeneration in the presence of a bioresorbable polymer scaffold. The result of the 
optimization procedure is a scaffold porosity distribution which maximizes the stiffness of the scaffold 
and regenerated bone system over the entire regeneration time, so that the propensity for mechanical 
failure is minimized.
The regeneration and restoration of skeletal functions of critical-sized bone defects are very challenging. Presently, 
regenerative therapy using absorbable scaffolds have shown promising results in vivo1–5 and in clinical cases6–9. 
During the bone regeneration processes, scaffolds act as a temporary supporting structure to (a) ensure that the 
defect/regeneration space is suitable for bone tissue growth, maturation and remodeling; (b) provide mechanical 
functionality for proper transfer of loads acting on scaffolds to the adjacent host tissues while tissue regenerates; 
and (c) facilitate in-growth of tissue and vasculature to accelerate tissue regeneration. Hence, the scaffolds’ archi-
tecture plays a crucial role during bone regeneration processes. Fundamentally, in the design of bone scaffolds, 
there are several functional characteristics to be considered, such as the porosity (or, inversely, the biomaterial 
volume fraction), pore size and pore shape, as these will affect the scaffolds’ permeability/diffusivity, degradation 
rate and elastic modulus, and in turn the biological processes necessary for regeneration10.
Due to the intricate relationships between scaffold geometries, mechanical properties, biomaterials and bio-
logical processes, research in bone tissue engineering has been dominated by trial-and-error approach – whereby 
an existing design is modified based on the experimental outcomes. This approach usually requires costly pro-
tocols and time-consuming experiments. Over the years, due to the rapid development of computer-aided engi-
neering (CAE) tools, topology optimization techniques have shown their potential as a powerful tool for the 
design of scaffold architectures. Topology optimization is a numerical process that iteratively distributes a given 
amount of material within a given design space under specific constraints such that the final structure meets spe-
cific design targets11,12. This technique has been applied to design scaffolds to topologically achieve the optimized 
architecture to match the desired porosity, elastic modulus and fluid permeability13–18.
One limitation common to most CAE models for topology optimization of bone scaffolds architectures is 
that the time-dependence of the regeneration process is not taken into account. Bone regeneration using scaf-
folds is a complex phenomenon involving different biophysical processes and scaffold/tissue interactions via their 
elastic moduli over time. To this end, various multi-scale models have been proposed and developed simulating 
bone regeneration processes in response to various scaffold properties (e.g., porosity, permeability, elastic modu-
lus), taking into account the time-evolution of the microstructure due to bone growth and scaffold resorption19. 
Hollister et al.20 proposed a topology optimization approach that can design a scaffold microstructure in order to 
meet the resulting conflicting design requirements.
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However, implementation of CAE into routine additive manufacturing (AM) workflows for optimization 
of scaffolds for regenerative medicine is impeded by the high computational cost. Here, we propose a simple, 
one-dimensional model for the optimization of bone scaffold architectures based on homogenized quantities. The 
main advantage of this model will be its efficiency for numerical computation. We can, therefore, use it as a first 
test case for a scaffold shape-optimization procedure, in particular with respect to finding suitable objective func-
tions to optimize. Our approach is thus related to the first step in the “Shape Optimization by the Homogenization 
Method”11 of optimizing within a relaxed problem for averaged quantities.
The remainder of this article is organized as follows. In the next section we introduce our simplified bone 
regeneration model and show some comparison to in-vivo studies. The section “Scaffold density optimization” 
describes the numerical optimization routine. The results of our numerical study and some discussion are pre-
sented thereafter. Finally, we present some conclusions and give an outlook on future work.
Development of a Scaffold-Mediated Bone Regeneration Model
In bone tissue engineering, the process of bone regeneration is commonly mediated by osteoconductive scaffolds 
that are often combined with growth factors and/or cells (osteoinductive). However, the exact mechanisms by 
which scaffold-mediated bone regeneration occurs are yet unclear. The process of bone regeneration is a complex 
and continuous process, but well orchestrated, starting from the formation of hematoma accompanied by the 
infiltration of inflammatory cells. Following the events of inflammation, bone regeneration can occur through 
either endochondral (bone formation through an intermediate cartilage phase) or intramembranous ossification 
(formation of new bone directly – usually occuring adjacent to existing bone). Finally, the regenerating bone 
enters the remodeling stage, where newly formed bone continues to remodel itself until a mechanically strong and 
highly organized bone structure is restored. The specific mechanism of bone regeneration guided by scaffolds is 
determined by the scaffolds’ architecture, which provides the immediate mechanobiological and chemical envi-
ronment where the cells reside.
For example, using collagen-based scaffolds (fabricated via freeze-drying techniques) with cylindrical pores 
aligned along the principal stress axis, Peterson et al.21 demonstrated the possibility of using solely the architec-
ture of scaffolds as a physical guiding structure to promote endochondral healing of bone defects in rats. Cipitria 
et al. and Paris et al.22,23 illustrated that 3D-printed scaffolds made from a composite of polycaprolactone (PCL, 
a slowly degrading synthetic thermoplastic) and β-tricalcium phosphate (β-TCP) with rectangle-shaped pores 
guide new bone formation through intramembranous ossification in sheep, extending from the proximal and 
distal end of the osteotomy site parallel to the tibial axis. In these studies21–23, it was noted that in the absence of 
exogenous growth factors or cells, no clinically relevant bridging of the defect was achieved. However, Pobloth 
et al.24 illustrated that 3D-printed titanium scaffolds with optimized mechanobiological properties can promote 
clinically relevant functional bridging of a critical-sized bone defect in a large animal model without the addition 
of exogenous growth factors or cells. Collectively, these studies indicate the possibility that scaffolds with optimal 
architecture and mechanobiological properties can guide and support endogenous bone regeneration.
In this study, the primary intention of the proposed scaffold-mediated bone regeneration model is to provide 
a basis for the scaffold architecture optimization algorithm proposed in the section “Scaffold density optimiza-
tion”. Hence, we propose a simple mathematical model capturing specific events occurring during the process of 
scaffold-mediated bone regeneration. Additionally, the model does take into consideration the time aspect of tis-
sue regeneration, considering both bone growth and scaffold degradation and the interaction of the two. The time 
evolution model tracks the time dependent quantities relevant for the mechanical integrity of the scaffold. These 
quantities are the molecular weight of the scaffold material (which diminishes over time due to degradation) and 
the amount of bone regenerated. The bone regeneration, however, depends on the local microenvironment. This 
includes (a) the presence of endogenous angiogenic and osteoinductive factors (e.g., growth factors/cytokines), 
which are excreted into, diffuse through, and decay in the extracellular matrix in the interstitial space, creating 
a local gradient through the regenerating tissue; and (b) the mechanical strain stimulus transmitted through the 
structure due to external mechanical loading, as it is well established that mechanical stimuli play a major role in 
bone regeneration25.
The system of equations for scaffold-mediated bone regeneration. A coupled system of evolution 
equations for these quantities, together with boundary conditions, has been established and constants in the 
model (e.g., the degradation rate of the scaffold material) have been deduced from experimental observations. We 
note that the model does not resolve these quantities on a fine (μm) scale, but uses coarse-grained values. These 
coarse-grained values can be interpreted as meso-scale averages over a number of pores in the scaffold material. 
For a scaffold that is additively manufactured based on a unit-cell design, the scaffold volume fraction is a spa-
tially varying parameter that changes on a larger length-scale than the unit cell size. Similarly, the regenerated 
bone density and other quantities in our model can be seen as locally averaged quantities. See Fig. 1 for an illus-
tration of a gyroid-type unit cell design. Other unit cell designs, for example, derived from shape optimization 
procedures, could of course be used. The basic underlying assumption of such homogenized models is that one 
can describe the evolution of these quantities again in terms of their averages.
The spatial domain of computation is the domain occupied by the scaffold. We simplify this domain to a 
one-dimensional object by only considering one of the main stress axes under physiological mechanical loading. 
This major reduction in complexity allows us to treat the resulting system of equations very efficiently, which is 
necessary for use in optimization. Of course, such a simplification requires some symmetry in the underlying 
three-dimensional setting such that the evolution of relevant quantities (e.g., regenerated bone density) can be 
captured in terms of quantities averaged over two of the three physical dimensions. The main drawback is that no 
optimization for the scaffold volume fraction can be performed in the two unresolved dimensions. Furthermore, 
only settings where there is one dominantly mechanically relevant axis can be treated. This is the case in our 
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application, i.e., an example of a segmental defect in a long bone. See the section “Comparison to experimental 
results” for a comparison to experimental results for scaffold-mediated bone regeneration in an ovine model.
Concretely, we solve the following system of differential equations (in space on the domain (0, L) and time for 
t ∈ (0, T]) for (1) the scaffold volume fraction ρ = 1 − θ with θ being the scaffold porosity, (2) the mechanical dis-
placement u, (3) the relative molecular weight of the scaffold material σ (normalized to be equal to unity for a new 
scaffold), (4) the density of bioactive molecules (growth factors/cytokines) a (normalized to unity for the density 
in healthy bone tissue under physiological mechanical loading), and (5) the relative bone density b (normalized 
to unity for healthy bone tissue).
ρ = 0 (occupied space does not change in time) (1)t
 ρ σ= b u0 ( ( , , ) ) (mechanical equilibrium) (2)x x
σ σ= −k (exponential loss of molecular weight) (3)t 1
ρ= + | | −a D a k u b k a( ( ) ) (diffusion, generation, and decay of bioactive molecules) (4)t x x x2 3
ρ
= | |


 − −



b k a u b
a
1
1
(bone growth proportional to and mechanical strain
but constrained by free volume) (5)
t x4
In this system, k1, k2, k3 and k4 are constant parameters, D, and  are functional relationships, all to be deter-
mined by experiment. Here, and in the remainder of the article, the subscript t denotes a time derivative, the 
subscript x denotes a spatial derivative.
The initial and boundary conditions for the respective variables are given by
ρ ρ= ∈x x x L( , 0) ( ) for all (0, ) (6)0
σ = ∈x x L( , 0) 1 for all (0, ) (7)
= ∈a x x L( , 0) 0 for all (0, ) (8)
= = ∈a t a L t t T(0, ) ( , ) 1 for all [0, ] (9)
γ= = ∈u t u L t L t T(0, ) 0, ( , ) for all [0, ] (10)
= ∈b x x L( , 0) 0 for all (0, ), (11)
i.e., in the beginning, the scaffold material with its given density (6) is fully intact (7), and no regenerated bone 
or active molecule is present (11), (8). The bone adjacent to the scaffold, however, produces the active molecules 
such that saturation is achieved there (9). The value for u(L, t) was chosen such that the scaffold is subject to a 
Figure 1. Coarse-Graining: above, a scaffold with varying local density; below, the coarse grained description 
of the local density.
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hard-loaded engineering strain γ (10). We note that the magnitude of the displacement boundary condition is 
arbitrary and could be normalized to unity by changing the parameter k4.
We note that our model includes local production of bioactive molecules only. An addition of a bone growth 
booster in the model could be implemented by changing the initial conditions for the function a. However, min-
imizing the required booster is relevant in particular for patients suffering from bone cancer.
Model parameters. This model assumes high molecular weight (Mw) PCL (~80 kDa) as the scaffold mate-
rial. In vivo, PCL shows a two-stage degradation pattern, predominantly by bulk erosion. The first stage involves a 
decrease in Mw without volume loss. The second stage of degradation begins when the Mw drops below 8000 Da, 
at which point the material becomes brittle and loss of volume occurs26, but this happens beyond the time scale 
considered here. Therefore, we consider no loss of volume fraction of the scaffold material to occur over time, 
yielding eq. (1) with no additional parameters.
The other parameters used for the model are listed in Table 1. They were determined as follows.
 (a) In humans, segmental bone defects are considered critical-sized when >2.5 cm27. In our model, the length 
of the scaffold was set at 30 mm, recapitulating a realistic critical-sized bone defect, as for example studied 
in an ovine model in28.
 (b) In a healthy individual, it is expected that with the appropriate clinical interventions, bone defects should 
be completely bridged with low to medium weight-bearing capacity after 6 months29. The process of bone 
remodeling would follow and may take 3 to 5 years to complete restoration of the full function of the 
bone30. Our current model considers bone regeneration over a span of 12 months, capturing the critical 
phase for scaffold-mediated healing with the scaffold acting as the support across the defect site in the 
initial phase until the formation of clinically functional bridging across the bone defect.
 (c) The PCL absorption rate constant, k1, was derived from experimental findings of Pitt et al.31, where PCL 
implanted into rabbits showed that after one year approximately 30% of the original Mw remains.
 (d) The constants k2 and k3, which govern the generation and decay rate of the bioactive molecules, are more 
difficult to obtain from the literature. The systemic half-life of recombinant human-bone morphogenetic 
protein-2 (rhBMP-2) was reported to be 16 minutes in rats and 6.7 minutes in non-human primates after IV 
administration, while BMP-732 and vascular endothelial growth factor (VEGF) exhibit a systemic half-life of 
30 minutes in rats33. Nonetheless, it has been widely shown that the local retention of bioactive molecules is 
prolonged in the presence of scaffolds34. For example, Kim et al.35 showed that PCL/PLGA scaffolds exhibit 
a sustained release of BMP-2 for 28 days in vitro – but such data is not necessarily applicable to our setting as 
we do not consider scaffolds functionalized with bioactive molecules for controlled release. Presently, there 
is a lack of experimental data on the generation and decay rate of bioactive molecules in the present of PCL 
scaffolds in the defect site. Our value for k2 corresponds to a half-life of approximately 6 hours, which yields a 
good agreement when comparing the model’s resulting regenerated bone density to experimental outcome, 
see “Comparison to experimental results”. For comparison, the simulation results for a half-life of approxi-
mately 30 minutes are discussed in the appendix “Further simulation results”, item (a), in the Supplementary 
Materials. The parameter k3 is set such that, for a constant bone density of 1 (i.e., healthy bone tissue) the 
equilibrium state for a is 1 as well (i.e., the normalized active molecule density in healthy bone tissue).
 (e) The diffusivity constant, k5 in D, is a standard value for the diffusion of bioactive molecules36 that is typical-
ly measured for soluble proteins37. In the functional relationship D(ρ) = 1 − ρ we account for the increased 
tortuosity of the microscopic diffusion domain due to the scaffold.
 (f) The relative modulus of bone vs. scaffold, k6, is chosen to agree with measurements (i.e, the ratio of the 
nano-indentation hardness for regenerated bone [28, Fig. 8(C), scaffold only] of 0.64 GPa and the nano-in-
dentation hardness for PCL [38, Table 5]) of 0.071 GPa. For the elastic modulus  we use the Voigt bound 
for composites, which simply corresponds to the sum of the elastic moduli of the scaffold and the regener-
ated bone, weighted by their respective volume fraction.
 (g) Finally, the regeneration parameter k4 is set such that a realistic regeneration outcome is achieved, see the 
section “Comparison to experimental results”.
Param. Value Description
T 12 months Period of bone regeneration considered in the model
L 30 mm Length of bone defect/scaffold considered in the model
γ 1% Hard-loaded engineering strain
D(ρ) k5(1 − ρ) Diffusivity of bioactive molecules in the scaffold occupied defect site
 ρ σ b( , , ) ρσ + k6b Elastic modulus for the scaffold/regenerated bone material composite
k1 0.1 per month PCL absorption rate constant
k2 k3/γ Generation rate of bioactive molecules
k3 80 per month Decay rate of bioactive molecules
k4 0.25/γ per month Rate of bone regeneration (healthy individual)
k5 100(μm)2/s ≈ 260 (mm)2/month Diffusivity of bioactive molecules without scaffold
k6 9.0 Relative modulus of bone vs. scaffold
Table 1. Parameters used for the bone regeneration model.
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Numerical implementation. In order to obtain a numerical approximation to the solution of our model, 
we employ a simple first-order-in-time Euler scheme, where in each time step the discrete equations are solved 
in the order that they are displayed above (with current values for the quantities substituted in each equation), 
and are thus decoupled. The diffusion equation for a as well as the elliptic equation for u are discretized in space 
using piecewise affine finite (i.e., P1) elements in one space dimension, see39 or40. The resulting ordinary differ-
ential equations for σ and a are discretized implicitly in time, the equation for b is discretized explicitly in time. 
The time-step is 0.1 months and the spatial discretization length is 0.4 mm. For details regarding the numerical 
implementation we refer to the MATLAB code, which is available as Supplementary Material.
Comparison to experimental results. The resulting regenerated bone matrix for the given parameters 
and two different constant values for the scaffolds’ volume fraction (ρ0 = 0.13 and ρ0 = 0.75, respectively) are 
shown in Fig. 2(a). Using the parameters from Table 1, and a constant scaffold volume fraction of 13%, our sim-
ulation yields a regenerated bone density of approximately 25% in the central region of the defect site (Fig. 2(a), 
green line). We note that an overly high volume fraction of scaffold material inhibits bone regeneration in our 
model (Fig. 2(a), red line), which is indeed an observed phenomenon in many studies (reviewed in41).
Detailed quantitative data for bone regeneration in the presence of a scaffold is unfortunately scarce. Our main 
comparison of the model outcome with experiment is thus limited to28. As can be deduced from [28, Fig. 1A,B], 
the scaffold used in the study done in28 has a volume fraction of approximately 13%. In Fig. 3 (reproduced from28 
with permission), the experimentally determined regenerated bone volume is shown after 3 and 12 months of 
scaffold-mediated bone regeneration in an ovine model. The relevant “scaffold only” regeneration data after 12 
months (Fig. 3(b)) shows a bone volume of approximately 75 mm3 in the central region. For a sample diameter of 
20 mm and slice height of 1 mm, as given in28, this corresponds to an averaged density of ≈
π ⋅( )
25%75 mm
mm 1 mm
3
20
2
2
, 
the same value our model yields. We also note that the overall shape – with a rather flat region of a constant 
amount of regenerated bone matrix in the central region – compares well to our results in Fig. 2(a), green line 
(ρ0 = 0.13). More quantitatively, we note that out of the 30 data points displayed in Fig. 3(b), for all but six of them, 
our simulation result lies within the first and third quartile box plots (after converting to regenerated densities as 
above). For all data points, our simulation result lies between the maximal and minimal experimental values. We 
note that the matching to the experimental data is slightly better at the distal end (x-values above 25 mm) than at 
the proximal end (x-values below 5 mm). It may therefore be possible to improve the matching by introducing 
spatially dependent model parameters – this, however, is beyond the scope of this article, as our focus lies on 
presenting an optimization method. Furthermore, one can compare the three month experimental data presented 
in Figs 3(a) to 4(a), which shows the regenerated bone density in our model after three months. The regenerated 
bone density in the central region of the defect is nearly zero in both experiment and simulation. Again, the 
model results lie within the first and third quartile for all but six experimental data points. The entire time and 
space dependence of the regenerated bone density is shown in Fig. 4(b). For comparison, the simulation results 
are overlaid in Fig. 3 for both the 3 month and the 12 month data. We note that the regenerated bone density 
increases with time extending from the proximal and distal ends of the defect parallel to the long bone axis. This 
pattern of scaffold-mediated bone regeneration has been reported previously21,28.
Scaffold Density Optimization
Using current additive manufacturing technologies, it is possible to generate unit-cell based scaffolds with any 
given porosity distribution ρ0 on the domain occupied by the implant. We note that this distribution of porosity 
is a major aspect of the scaffold architecture. The solution of the evolution equations in our model now allows 
the deduction of, for example, the rate of proliferation of newly generated bone matrix within the implant, all 
dependent on the initial scaffold porosity distribution.
Figure 2. Outcome of the model without optimization.
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The model above can furthermore be used to evaluate the time evolution of the mechanical stiffness (i.e., 
effective elastic modulus of the structure stemming from both the scaffold material and the regenerated bone) of 
the implant for a given ρ0. This mechanical stiffness is (in our case) proportional to the total elastic energy in the 
system at time t ∈ [0, T],
∫ ρ σ=E t u x t x t x t b x t u x t x( ) ( , ) ( ( , ), ( , ), ( , )) ( , ) d , (12)
L
x x
el
0
where ρ, σ, u, and b follow Eqs (1–5) above (and thus depend on ρ0). We note that the elastic energy in the system 
is given by the integral over the elastic energy density, which in turn is given by the strain ux (the spatial derivative 
of the displacement u) multiplied by the stress, i.e., the elastic modulus  multiplied again by the strain. 
Figure 2(b) shows the evolution of E in time for the two unoptimized test cases.
It is now possible to maximize the minimum over the regeneration time of the overall mechanical stiffness
ρ =
∈
E E t( ) min ( )
(13)t T
min
0 [0, ]
el
of the scaffold among all physiologically suitable (e.g., with a cutoff to ensure ρ0(x) ≤ 0.7 in order to not prevent 
vascularization) initial scaffold porosity distributions.
Figure 3. Experimentally determined regenerated bone volume, from28, reproduced and adapted with 
permission. Since we consider bone regeneration without the aid of rhBMP-7, we are interested in the scaffold-
only data (light colored bars). The box plots indicate median, 25th and 75th percentiles, respectively. The 
vertical lines indicate maximum and minimum values. The green line represents the respective simulation 
results (as displayed in Figs 2(a) and 4(a)), scaled appropriately.
Figure 4. Regenerated bone density and its space and time dependence.
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It is important to note that for PCL scaffolds such an optimization is a reasonable approach. For certain 
titanium-mesh scaffolds it has been found that softer scaffolds yield better regeneration results24 – PCL, however, 
is already a material that is less stiff than bone. Therefore, it is not an issue here to obtain sufficient mechanical 
stimulus for bone regeneration. Instead, the main drawback of PCL scaffolds is their potential for mechanical 
failure, which can be minimized by maximizing their mechanical stiffness.
We implement this optimization by the established method of using a gradient flow with respect to the objec-
tive function Emin. To be more precise, we calculate an approximation of the Fréchet derivative δ ρρ E ( )
min
00
 (in the 
discretized setting, this is the gradient of Emin with respect to the coefficients in the spatial discretization of ρ0) by 
using finite differences in each node of the discretization of ρ0, i.e., one coefficient in the discretization of ρ0 is 
varied slightly and the resulting difference in Emin is stored as the finite difference with respect to this coefficient. 
Then a gradient ascent with a soft pointwise constraint on the volume fraction is performed, where the soft con-
straint is implemented by adding a penalty function to the objective, which attains large negative values once ρ0 
becomes too large. The method is illustrated in the flowchart in the appendix “Flowchart of the optimization 
algorithm” in the Supplementary Materials. The computational cost for such an optimization method is easily 
manageable due to the use of coarse grained values in the evolution equation system. Our MATLAB implemen-
tation performs a full optimization and reaches a stationary state of the gradient ascent in a few minutes on a 
regular desktop computer, thus more sophisticated methods were not deemed necessary. Our method can there-
fore yield an optimized scaffold design, adapted to a given mechanical load and other (possibly patient specific) 
parameters.
Results and Discussion
We have devised a simple model for bone regeneration that is suitable for use in an optimization routine for poly-
mer bone scaffolds. Generally, one can establish a hierarchy of models for bone regeneration, from fully resolved 
microscopic models treating the entire device, to homogenized (coarse grained) models in three, and finally in 
one space dimension. Fully resolved models for bone regeneration, however, tend to be too computationally 
expensive to be used for optimization, as the computation time for one single run of such a model can be on the 
order of 30 minutes42 on a large scale (56 thread) compute server, and more than 100 runs can be necessary to 
determine an optimal scaffold43. A different route of simplification is to restrict oneself to a single unit cell in a 
periodic scaffold design. This approach is taken for example in13,44. The advantage of our coarse grained method 
is that, while neglecting the microscopic properties, the entire device can be treated numerically and optimized 
within minutes on a standard desktop machine.
Generally, we remark that our model can be verified using experimental data by comparing the time depend-
ent regenerated bone density, which can be assessed from tomography results in in-vivo studies. Such a compari-
son was performed in the section “Comparison to experimental results”.
In our model, as a proxy for the mechanical stability of such scaffolds, we maximize the effective elastic modu-
lus of the combination of scaffold and regenerated bone material, after taking the minimum effective elastic mod-
ulus over the regeneration time. With this method, it is possible to find optimized volume fraction distributions 
for additively manufactured scaffolds based, e.g., on periodic unit cell designs (Fig. 1). These unit cell designs 
could, for example, stem from the aforementioned periodic topology optimization methods. In addition to the 
effective elastic modulus of the device, we implement a penalty for overly large scaffold volume fraction, as this 
would prevent for example vascularization (a rather shorter time-scale process which is not directly captured in 
our model). A lower bound for the scaffold volume fraction does not need to be implemented explicitly, as such a 
local weak point would be directly captured in a diminished effective elastic modulus.
Figure 5 shows a comparison of the optimized scaffold designs (Fig. 5(a)) and the corresponding normalized 
effective elastic moduli over time (Fig. 5(b)). The minimal elastic modulus values for all designs are listed in 
Table 2. In particular, we also compare the optimization among constant-volume fraction scaffolds. In our model, 
with the parameters given in Table 1, the difference in the minimal elastic modulus between the full optimization 
and the optimization restricted to constant volume fractions is approximately 8%. The full optimization yields 
an optimal scaffold with higher density in the middle region – this can, of course, be understood from heuristic 
arguments: the regenerated bone grows back at the ends where the scaffold is attached to the intact bone matrix. 
Thus, in the central region, the scaffold polymer has to maintain the structural integrity for a longer time by itself, 
while undergoing bulk erosion.
We remark that our model is still very simplistic and a number of parameters are not known exactly due to the 
lack of quantitative experimental data. However, the aforementioned general outcome of optimal scaffold designs 
that increase their volume fraction in their central region (in order to provide more stability until the regenerated 
bone reaches the center) and decrease their volume fraction at the edges (in order to not impede bone-ingrowth) 
holds for a large range of different parameters. For illustration we discuss two more numerical examples for scaf-
fold optimization in appendix “Further simulation results” in the Supplementary Materials.
In the real world, critical-sized bone defects are more prominent in patients with compromised endoge-
nous bone healing capability, for example, due aging45 or bone-related metabolic disorders like osteoporosis46. 
Hence, we performed a test case for the generation of a scaffold with optimal porosity distribution for patients 
with compromised endogenous bone healing capability. This numerical experiment was conducted with the 
bone-regeneration coefficient reduced to k4 = 0.125/γ and the stiffness ratio to k6 = 4.5, to emulate a patient with 
reduced regeneration capacity, for example, due to osteoporosis. The minimal elastic modulus of the scaffold 
performed with full optimization and the optimization among constant ρ0 are listed in Table 2 – with a difference 
of nearly 40% (Emin = 0.36 vs. Emin = 0.26). The porosity distribution of scaffolds (for reduced bone regeneration 
capability) and the corresponding elastic moduli are plotted in Fig. 6.
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We argued that the general shape of the optimal scaffold density distribution can be understood from heuristic 
arguments. It is thus particularly interesting to note the following. When we model the bone regeneration process 
for a scaffold optimized for a healthy patient (black line in Fig. 5(a), optimized for k4 = 0.25/γ, k6 = 9.0), but using 
model parameters of a patient with reduced regeneration capacity (k4 = 0.125/γ, k6 = 4.5), we get a significantly 
lower Emin = 0.28 than when we model a scaffold that has been optimized from the start specifically for a patient 
with reduced regeneration capacity (black line in Fig. 6(a), yielding Emin = 0.36 – an increase of nearly 29%). This 
shows that our model can benefit tremendously from patient-specific parameters to produce patient-specific 
optimal scaffold designs. A purely heuristic approach, based solely on the idea that a scaffold should be denser in 
the central region, would thus give an inferior result.
Figure 5. Comparison of scaffold optimization results.
ρ0 = 0.13 0.13
ρ0 = 0.75 0.45
Optimization among constant ρ0 0.50
Full optimization 0.54
Optimization among constant ρ0 (reduced bone regeneration) 0.26
Full optimization (reduced bone regeneration) 0.36
Reduced bone regeneration but ρ0 optimized for regular patient 0.28
Table 2. Comparison of minimal elastic modulus Emin(ρ0) for the scaffold designs under consideration. The 
values are normalized such that the scaffold material PCL has an elastic modulus of 1.
Figure 6. Comparison of scaffold optimization results for the model with reduced bone regeneration, i.e., 
k4 = 0.125/γ and k6 = 4.5.
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Conclusions
We presented an optimization method for bone scaffold design, which is based on an efficient, coarse grained 
model for bone regeneration. The regeneration parameters in the model have been determined from the literature 
and the outcome of the model was compared to experimental results. The model presented here can of course 
be further extended to include spatially dependent regeneration parameters or more sophisticated models for 
the scaffold decay (for example by including a dependence on the strain), as more experimental data becomes 
available.
Presently, diagnosis of bone defects is highly dependent on X-ray micrographs, which only provide visual 
guidance for treatment and management and lack precise information on the patient’s intrinsic bone regener-
ation capability. Potentially, this could be overcome by leveraging Omics technology and multi-model analy-
sis through bioinformatics techniques to improve patient stratification in terms of intrinsic bone regeneration 
capability while unraveling the underlying biological mechanisms that govern the bone regeneration cascade. 
The inclusion of such patient-specific parameters would significantly improve the herein proposed optimization 
model for personalized bone scaffold designs. Nonetheless, such an endeavor will require long-term synergistic 
and complementary research efforts across a multitude of disciplines.
Hence, within the scope of design optimization, future work includes refinement of the model in order to be 
better aligned with experimental results, considering also finely resolved descriptions of bone regeneration in 
the presence of scaffolds, e.g.47. An extension to a three dimensional coarse grained regeneration model is also 
currently being examined.
Data Availability
This work does not have any experimental data. The MATLAB-code for scaffold optimization is made available 
as Supplementary Material.
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